Soluble intercellular adhesion molecule-1 (sICAM-1) and soluble interleukin-2 receptors (sIL-2R) in scleroderma skin

被引:0
|
作者
Sondergaard, K
Stengaard-Pedersen, K
Zachariae, H
Heickendorff, L
Deleuran, M
Deleuran, B
机构
[1] Aarhus Univ Hosp, Dept Rheumatol, Res Lab, DK-8000 Aarhus C, Denmark
[2] Aarhus Univ Hosp, Dept Dermatol, DK-8000 Aarhus C, Denmark
[3] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus C, Denmark
来源
BRITISH JOURNAL OF RHEUMATOLOGY | 1998年 / 37卷 / 03期
关键词
cell adhesion molecules; sICAM-1; sIL-2R; interleukin-2; receptors; systemic sclerosis; CD54; CD25;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In order to investigate whether soluble intercellular adhesion molecule-1 (sICAM-1) and soluble interleukin-2 receptors (sIL-2R) were present in scleroderma skin, and to compare their levels to concentrations measured in plasma and clinical parameters, we examined suction blister fluid and plasma from 13 patients with systemic sclerosis and 11 healthy volunteers. Suction blisters and biopsies were from the transition zone between normal skin and scleroderma, and uninvolved abdominal skin. The levels of sICAM-1 and sIL-2R were significantly increased in both plasma and suction blister fluid from systemic sclerosis patients compared with healthy volunteers. ICAM-1 was localized to vessels and perivascular mononuclear infiltrates by immunohistochemical methods. IL-2R was expressed by CD3-positive cells. The elevated levels of sICAM-1 and sIL-2R in suction blister fluid point towards activation of endothelial cells and T cells in both the transition zone and uninvolved skin of systemic sclerosis patients.
引用
收藏
页码:304 / 310
页数:7
相关论文
共 50 条
  • [41] Serum levels of soluble intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and interleukin-2 receptor in patients with vernal keratoconjunctivitis and allergic conjunctivitis
    Uchio, E
    Ono, S
    Ikezawa, Z
    Ohno, S
    ALLERGY, 1999, 54 (02) : 135 - 141
  • [42] Soluble interleukin-2 receptors (sIL-2R) in ovarian cancer patients:: changes in sIL-2R after surgery as a prognostic factor?
    Gebauer, G
    Rieger, M
    Jäger, W
    Lang, N
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1998, 13 (01): : 45 - 47
  • [43] COMPARATIVE ANTIRHINOVIRAL ACTIVITIES OF SOLUBLE INTERCELLULAR-ADHESION MOLECULE-1 (SICAM-1) AND CHIMERIC ICAM-1 IMMUNOGLOBULIN-A MOLECULE
    CRUMP, CE
    ARRUDA, E
    HAYDEN, FG
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (06) : 1425 - 1427
  • [44] A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma
    Stelmach, I
    Jerzynska, J
    Kuna, P
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (02) : 257 - 263
  • [45] SOLUBLE INTERLEUKIN-2 RECEPTOR (SIL-2R) IN RHEUMATOID-ARTHRITIS
    HERZOG, C
    HERZOG, A
    AESCHLIMANN, A
    GERBER, H
    MULLER, W
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 1990, 49 (01): : 8 - 10
  • [46] Increased mucosal concentrations of soluble intercellular adhesion molecule-1 (sICAM-1), sE-selectin, and interleukin-8 in active ulcerative colitis
    Nielsen, OH
    Brynskov, J
    Vainer, B
    DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (09) : 1780 - 1785
  • [47] Evaluation of soluble intracellular adhesion molecule-1 (sICAM-1) in benign and malignant ovarian masses
    Opala, T
    Drews, K
    Rzymski, P
    Wozniak, J
    Sajdak, S
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2003, 24 (3-4) : 255 - 257
  • [48] Soluble intercellular adhesion molecule-1 (sICAM-1) and aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis (MESA)
    Shavelle, David M.
    Katz, Ronit
    Takasu, Junichiro
    Lima, Joao A.
    Jenny, Nancy S.
    Budoff, Matthew J.
    O'Brien, Kevin D.
    JOURNAL OF HEART VALVE DISEASE, 2008, 17 (04): : 388 - 395
  • [49] Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications
    S Viviani
    E Camerini
    V Bonfante
    A Santoro
    M Balzarotti
    M Fornier
    L Devizzi
    P Verderio
    P Valagussa
    G Bonadonna
    British Journal of Cancer, 1998, 77 : 992 - 997
  • [50] Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications
    Viviani, S
    Camerini, E
    Bonfante, V
    Santoro, A
    Balzarotti, M
    Fornier, M
    Devizzi, L
    Verderio, P
    Valagussa, P
    Bonadonna, G
    BRITISH JOURNAL OF CANCER, 1998, 77 (06) : 992 - 997